DiagnaMed Holdings launches Cervai brain health AI solution
DiagnaMed Holdings Corp., a digital health artificial intelligence company focused on brain health, announced the pilot launch of Cervai, a world-first consumer brain health and wellness AI solution that aims to ‘raise a red flag’ for potential brain health issues by estimating brain age and providing a brain health score.
Fabio Chianelli, chairman and CEO of DiagnaMed, commented: “After over two years in development, Cervai, a world-first consumer brain health and wellness solution that estimates brain age and provides a brain health score, is available to clinics seeking to provide a unique service that helps bridge the gaps in physical and cognitive health while enhancing client engagement and design personalized interventions in improving overall brain health."
Based on research and development at Drexel University and the University of Miami, Cervai combines a Brain Age Estimation and Brain Health Assessment tool. Cervai can assess if a brain is aging more quickly or more slowly than is typical for healthy individuals. Brain age is estimated by collecting neural activity data of the brain with a low-cost and easy-to-use electroencephalogram (EEG) headset and calculating the data with a proprietary machine-learning model. In addition, Cervai can assess if a person has a healthy brain or is in the early stage of cognitive decline. Brain health is scored by taking a clinically validated assessment for brain resilience, vulnerability and performance functions. Individuals can seek out personalized diagnostics and interventions, such as medication or lifestyle changes, that may help to decrease the development or progression of cognitive decline.
The Cervai Brain Health pilot programme is open to a select 25 consumer wellness clinics in the US and Canada over the next three months. Ideal clinics for the pilot program must focus on health and wellness, sports and physical therapy, mental health, chiropractic care, or clinical research for neurological and cognitive disorders.
DiagnaMed Holdings Corp. (is a digital health artificial intelligence company focused on commercializing Cervai, a world-first consumer brain health and wellness AI solution that aims to ‘raise a red flag’ for potential brain health issues by estimating brain age and providing a brain health score.

Optimize Your trial insights with Clival Database.
Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.
With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.
To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.
Elevate your trial success rate with the cutting-edge insights from Clival database.
Check it out today and make more informed sourcing decisions! Learn More!